Mineralys Therapeutics: Ownership Change Reported
Ticker: MLYS · Form: 4 · Filed: Apr 21, 2026 · CIK: 0001933414
Sentiment: neutral
Topics: insider-transaction, ownership-change
TL;DR
Insider Rodman changed his Mineralys stake on 4/17. Details TBD.
AI Summary
On April 17, 2026, David Malcom Rodman reported a change in beneficial ownership of securities for Mineralys Therapeutics, Inc. The filing details transactions related to his holdings, but specific dollar amounts and the exact nature of the transactions are not provided in this summary.
Why It Matters
This filing indicates a change in the beneficial ownership of securities by an insider, which can provide insights into insider confidence and potential future stock movements.
Risk Assessment
Risk Level: low — Form 4 filings typically report routine changes in insider holdings and do not inherently signal significant risk unless specific large transactions or patterns emerge.
Key Players & Entities
- Mineralys Therapeutics, Inc. (company) — Issuer
- David Malcom Rodman (person) — Reporting Person
- 0001672659-26-000024 (filing_id) — SEC Accession Number
- 2026-04-17 (date) — Period of Report
FAQ
Who is the reporting person in this filing?
The reporting person is David Malcom Rodman.
What is the name of the issuer?
The issuer is Mineralys Therapeutics, Inc.
What type of form is this filing?
This is a Form 4 - Statement of changes in beneficial ownership of securities.
On what date is the period of report?
The period of report is 2026-04-17.
What is the SEC Accession Number for this filing?
The SEC Accession Number is 0001672659-26-000024.
Filing Details
This Statement of Changes in Beneficial Ownership (Form 4) was filed with the SEC on April 21, 2026 by David Malcom Rodman regarding Mineralys Therapeutics, Inc. (MLYS). Form 4 filings disclose purchases, sales, or other changes in ownership by company insiders such as officers, directors, and major shareholders.